CG Oncology, Inc. is a late-stage clinical biopharmaceutical company developing cretostimogene grenadenorepvec, an investigational oncolytic immunotherapy with a dual mechanism of action designed to eliminate cancer cells via selective replication and activate anti-tumor immune responses. It targets bladder cancer, specifically high-risk and intermediate-risk non-muscle invasive bladder cancer (NMIBC), representing up to 150,000 addressable patients. The company has initiated a BLA submission to the FDA and has received Fast Track and Breakthrough Therapy designations.
Q2 FY2026 — expected 2026-09-07
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-27 | 2025-12-31 | 0001193125-26-079498 | EDGAR | 98K words |
| 2025-03-28 | 2024-12-31 | 0000950170-25-046351 | EDGAR | 95K words |
| 2024-03-26 | 2023-12-31 | 0000950170-24-036143 | EDGAR | 110K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001193125-26-336918 | EDGAR | 22K words |
| 2025-11-14 | 2025-09-30 | 0001193125-25-283000 | EDGAR | 25K words |
| 2025-08-08 | 2025-06-30 | 0000950170-25-105855 | EDGAR | 24K words |
| 2025-05-13 | 2025-03-31 | 0000950170-25-069831 | EDGAR | 19K words |
| 2024-11-12 | 2024-09-30 | 0000950170-24-124642 | EDGAR | 22K words |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093238 | EDGAR | 21K words |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056196 | EDGAR | 18K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001193125-26-336886 | EDGAR | 2K words |
| 2026-02-27 | 0001193125-26-079452 | EDGAR | 2K words |
| 2026-01-13 | 0001193125-26-011855 | EDGAR | 1K words |
| 2026-01-09 | 0001193125-26-008329 | EDGAR | 5K words |
| 2025-11-26 | 0001193125-25-298160 | EDGAR | 1K words |
| 2025-11-14 | 0001193125-25-283108 | EDGAR | 1K words |
| 2025-11-14 | 0001193125-25-281672 | EDGAR | 2K words |
| 2025-09-09 | 0001991792-25-000007 | EDGAR | 5K words |
| 2025-09-05 | 0001991792-25-000004 | EDGAR | 1K words |
| 2025-08-08 | 0000950170-25-105487 | EDGAR | 2K words |
42 total filings indexed. 22 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001991792 |
| Ticker | CGON |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.cgoncology.com |
| Listed | 2024-01-25 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CGON (~200 tokens, structured JSON with cryptographic provenance)